Navigation Links
Strategic Overview of Global Preventable Vaccine Market 2012-2016
Date:4/19/2013

NEW YORK, April 19, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Strategic Overview of Global Preventable Vaccine Market 2012-2016

http://www.reportlinker.com/p01162225/Strategic-Overview-of-Global-Preventable-Vaccine-Market-2012-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

TechNavio's analysts forecast the Strategic Overview of Global Preventable Vaccine Market to grow at a CAGR of 8.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in demand for vaccination. The Strategic Overview of Global Preventable Vaccine market has also been witnessing the trend of increase in market consolidation. However, the emergence of regional players could pose a challenge to the growth of this market.

TechNavio's report, the Strategic Overview of Global Preventable Vaccine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Strategic Overview of Global Preventable Vaccine Market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include GlaxoSmithKline plc. Sanofi Pasteur SA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Emergent BioSolutions Inc .

Key questions answered in this report:

What will the market size be in 2016 and at what will be the growth rate? What are key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by key vendors? What are the strengths and weaknesses of each of these key vendors?

Methodology Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

01. Executive Summary 02. List of Abbreviations 03. Introduction 04. Market Research Methodology Market Research Process Research Design Research Methodology 05. Scope of the Report Market Overview Product Offerings 06. Vaccine 06.1 Introduction 06.2 Types of Vaccines Live Attenuated (weakened) Vaccine Killed (inactivated) Vaccine Toxoid Vaccine Genetically Modified/Engineered Vaccine 06.3 Subunit Vaccines 06.4 Conjugate Vaccines 06.5 DNA Vaccines 06.6 Recombinant Vector Vaccines 06.7 Vaccine Approval Process 07. Global Preventable Vaccines Market 07.1 Market Size and Forecast 07.2 Global Preventable Vaccine Market Segmentation 07.3 Global Preventable Vaccine Market Share by Vaccine Type 2012 07.4 Global Preventable Vaccine Market by Revenue 2012-2016(US$ billions) 08. Competitive Landscape of Global Preventable Vaccine Market 08.1 Global Preventable Vaccine Market Share by Vendor 2012 08.2 Global Preventable Vaccine Market Share by Vaccine Type 2016 08.3 Global Preventable Vaccine Market Share by Vaccine Type 2012-2016 09. Geographical Analysis of Global Preventable Vaccines Market 09.1 Market Size and Forecast for the US 09.2 Market Size and Forecast for EU 09.3 Market Size and Forecast for Japan 09.4 Market Size and Forecast for India 09.5 Market Size and Forecast for China 09.6 Market Size and Forecast for ROW 10. Global Pediatric Preventable Vaccines Market 10.1 Global Pediatric Preventable Vaccines Market Market Size and Forecast 10.2 Market Segmentation of Global Pediatric Preventable Vaccine 10.3 Global Pediatric Hepatitis Vaccine Market Market Size and Forecast 10.4 Global Pediatric Haemophilus Influenzae Type B (Hib) Vaccine Market Market Size and Forecast 10.5 Global Pediatric Measles, Mumps and Rubella (MMR) Vaccine Market Market Size and Forecast 10.6 Global Pediatric Combination Vaccines Market Market Size and Forecast 10.7 Global Pediatric Pneumococcal Vaccine Market Market Size and Forecast 10.8 Global Polio Vaccine Market Market Size and Forecast 10.9 Global Pediatric Varicella Vaccine Market Market Size and Forecast 10.10 Global Other Pediatric Vaccine Market Market Size and Forecast 10.11 Global Pediatric Preventable Vaccine Market 2012-2016 (Percentage) 11. Pipeline Assessment of Pediatric Preventable Vaccine Market 12. Competitive Landscape of Global Pediatric Preventable Vaccine Market 12.1 Global Pediatric Preventable Vaccine Market Share by Vendor 2012 12.2 Global Pediatric Preventable Vaccine Market Share by Vaccine Type 2012 12.3 Global Pediatric Preventable Vaccine Market Share by Vaccine Type 2016 13. Geographical Segmentation of Pediatric Preventable Vaccine Market 14. Global Pediatric Preventable Vaccines Market by Regions 14.1 Market Size and Forecast for the US 14.2 Market Size and Forecast for EU 14.3 Market Size and Forecast for Japan 14.4 Market Size and Forecast for India 14.5 Market Size and Forecast for China 14.6 Market Size and Forecast for ROW 15. Global Adult Preventable Vaccines Market 15.1 Global Adult Preventable Vaccines Market Market Size and Forecast 15.2 Market Segmentation of Global Adult Preventable Vaccine 15.3 Global Cervical Vaccine Market Market Size and Forecast 15.4 Global Hepatitis Vaccine Market Market Size and Forecast 15.5 Global Influenza Vaccine Market Market Size and Forecast 15.6 Global Adult Pneumococcal Vaccine Market Market Size and Forecast 15.7 Global Travel, Diphtheria-Tetanus, Miscellaneous Vaccine Market Market Size and Forecast 16. Pipeline Assessment of Adult Preventable Vaccine Market 17. Competitive Landscape of Global Adult Preventable Vaccine Market 17.1 Global Adult Preventable Vaccine Market Share by Vendor 2012 17.2 Global Adult Preventable Vaccine Market Share by Vaccine Type 2012 17.3 Global Adult Preventable Vaccine Market Share by Vaccine Type 2016 18. Geographical Segmentation of Adult Preventable Vaccine Market 19. Global Adult Preventable Vaccines Market by Regions 19.1 Market Size and Forecast for US 19.2 Market Size and Forecast for EU 19.3 Market Size and Forecast for Japan 19.4 Market Size and Forecast for India 19.5 Market Size and Forecast for China 19.6 Market Size and Forecast for ROW 20. Buying Criteria 21. Market Growth Drivers 22. Drivers and their Impact 23. Market Challenges 24. Impact of Drivers and Challenges 25. Market Trends 26. Key Vendor Analysis 26.1 Sanofi Pasteur SA Business Overview Key Information SWOT Analysis 26.2 GlaxoSmithKline plc. Business Overview Key Information SWOT Analysis 26.3 Pfizer Inc. Business Overview Key Information SWOT Analysis 26.4 Novartis AG Business Overview Key Information SWOT Analysis 26.5 Merck & Co. Inc. Business Overview Key Information SWOT Analysis 26.6 Emergent BioSolutions Inc. Business Overview Key Information SWOT Analysis 27. Other Reports in this Series

List of Exhibits: Exhibit 1: Market Research Methodology

Exhibit 2: Categorization of Global Preventable Vaccine Market

Exhibit 3: Vaccine Approval Process

Exhibit 4: Global Preventable Vaccines Market 2012-2016 (US$ billions)

Exhibit 5: Preventable Vaccines market in US 2012-2016 (US$ billions)

Exhibit 6: Preventable Vaccines market in EU 2012-2016 (US$ billions)

Exhibit 7: Preventable Vaccines market in Japan 2012-2016 (US$ billions)

Exhibit 8: Preventable Vaccines market in India 2012-2016 (US$ billions)

Exhibit 9: Preventable Vaccines market in China 2012-2016 (US$ billions)

Exhibit 10: Preventable Vaccines market in ROW 2012-2016 (US$ billions)

Exhibit 11: Geographical Analysis of Global Preventable Vaccines Market 2012-2016 (US$ billions)

Exhibit 12: Geographical Analysis of Global Preventable Vaccines Market 2012-2016 (CAGR values)

Exhibit 13: Global Pediatric Preventable Vaccines Market 2012-2016 (US$ billions)

Exhibit 14: Global Pediatric Hepatitis Vaccine Market 2012-2016 (US$ billions)

Exhibit 15: Global Pediatric Haemophilus Influenzae Type B Market 2012-2016 (US$ billions)

Exhibit 16: Global Pediatric Measles, Mumps and Rubella (MMR) Vaccine Market 2012-2016 (US$ billions)

Exhibit 17: Global Pediatric Combination Vaccines Market 2012-2016 (US$ billions)

Exhibit 18: Global Pediatric Pneumococcal Vaccine Market 2012-2016 (US$ billions)

Exhibit 19: Global Polio Vaccine Market 2012-2016 (US$ billions)

Exhibit 20: Global Pediatric Varicella Vaccine Market 2012-2016 (US$ billions)

Exhibit 21: Global Other Pediatric Vaccine Market 2012-2016 (US$ billions)

Exhibit 22: Global Pediatric Preventable Vaccine Market by Geographical Segmentation 2012

Exhibit 23: Pediatric Preventable Vaccines market in US 2012-2016 (US$ billions)

Exhibit 24: Pediatric Preventable Vaccines market in EU 2012-2016 (US$ billions)

Exhibit 25: Pediatric Preventable Vaccines market in Japan 2012-2016 (US$ billions)

Exhibit 26: Pediatric Preventable Vaccines market in India 2012-2016 (US$ billions)

Exhibit 27: Pediatric Preventable Vaccines market in China 2012-2016 (US$ billions)

Exhibit 28: Pediatric Preventable Vaccines market in ROW 2012-2016 (US$ billions)

Exhibit 29: Global Adult Preventable Vaccines Market 2012-2016 (US$ billions)

Exhibit 30: Global Cervical Vaccine Market 2012-2016 (US$ billions)

Exhibit 31: Global Hepatitis Vaccine Market 2012-2016 (US$ billions)

Exhibit 32: Global Influenza Vaccine Market 2012-2016 (US$ billions)

Exhibit 33: Global Adult Pneumococcal Vaccine Market 2012-2016 (US$ billions)

Exhibit 34: Global Travel, Diphtheria-Tetanus, Miscellaneous Vaccine Market 2012-2016 (US$ billions)

Exhibit 35: Global Adult Preventable Vaccine Market by Geographical Segmentation 2012

Exhibit 36: Adult Preventable Vaccines market in US 2012-2016 (US$ billions)

Exhibit 37: Adult Preventable Vaccines market in EU 2012-2016 (US$ billions)

Exhibit 38: Adult Preventable Vaccines market in Japan 2012-2016 (US$ billions)

Exhibit 39: Adult Preventable Vaccines market in India 2012-2016 (US$ billions)

Exhibit 40: Adult Preventable Vaccines market in China 2012-2016 (US$ billions)

Exhibit 41: Adult Preventable Vaccines market in ROW 2012-2016 (US$ billions)

To order this report:Drug_and_Medication Industry: Strategic Overview of Global Preventable Vaccine Market 2012-2016

Contact Clare: clare@reportlinker.com

US:(339) 368 6001

Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
2. AnaptysBio Announces New Strategic Antibody Discovery
3. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
4. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
5. Strategic Analysis of the Collagen Peptide Market in the United States
6. SiREM and Tersus Environmental Form Strategic Marketing Alliance
7. Chemring Detection Systems Awarded $500k for Strategic Research and Development
8. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
9. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
10. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
11. Genomic Health and OncoMed Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)...  Spectra BioPharma Selling Solutions (Spectra) is a ... companies the experience, expertise, operational delivery and customer ... teams. Created in concert with industry leading commercial ... and tactical needs of its clients by providing ... personal and non-personal promotion. --> ...
(Date:2/11/2016)... 2016  Dovetail Genomics™ LLC today announced that it ... a planned metagenomic genome assembly service. Richard Green ... assembly method in a talk on Friday, February 12 ... conference in Orlando, Fla. ... is difficult. Using its proprietary Chicago ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... for more than 150 years, continues today to pursue the highest level of ... of analytical instruments: the AR9 Refractometer and the AR5 Refractometer. Accurate, reliable ...
(Date:2/10/2016)... 2016 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), ... that Mitsui & Co. Ltd., its partner in the ... is investing an additional CDN$25 million in the joint ... from 30% to 40%.  Mitsui will also play a ... in Sarnia , providing dedicated resources ...
Breaking Biology Technology:
(Date:2/11/2016)... , Feb. 11, 2016  According to new ... officially mainstream. More than 200 fingerprint, iris, and ... 2013 under 70 brand names. This includes market ... and ZTE. Acuity projects that 600 million biometric ... the global installed base. Maxine Most ...
(Date:2/11/2016)... , Feb. 11, 2016  Vigilant Solutions announces today that ... are being used by Lee,s Summit ... recent location and arrest of a homicide suspect. ... covers around 65 square miles and is home to ... Department has a single mobile license plate reader system and ...
(Date:2/10/2016)... India , February 10, 2016 /PRNewswire/ ... --> According to 2016 iris recognition ... identification iris recognition is more widely accepted ... available with both fingerprint and iris recognition ... the user to avoid purchasing two individual ...
Breaking Biology News(10 mins):